questionText: To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of Creon to treat Type 2 diabetes.
answerText: The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used by patients with conditions such as type 2 diabetes, cystic fibrosis, and certain cancers, including p...
heading: Pancreatin